Turmeric for Digestive Health

Turmeric is famous in the English-speaking world as an anti-inflammatory — something you take for your knees. That is not how most of the world has used it, and it is not where its longest track record lies. Turmeric's oldest and best-evidenced everyday use is for the upper gut: the heavy, over-full, gassy, slightly nauseated feeling that settles in after a meal and will not shift. Indigestion. Fullness. Bloating. The complaint that sends more people to a pharmacy than almost anything else.

This is not folklore dressed up as medicine. It is the indication turmeric capsules are sold and officially recognised for in Thailand, where they sit on ordinary pharmacy shelves beside the antacids, and it is the indication that the two most important clinical trials of turmeric for digestion were designed to test — both of them run by Thai researchers, thirty-four years apart. The 1989 trial compared turmeric capsules against placebo and against a commercial anti-flatulence remedy. The 2023 trial compared curcumin against omeprazole, one of the most prescribed drugs on earth, and against the two combined.

There is a second reason the gut is turmeric's strongest ground, and it is slightly counter-intuitive. Turmeric's great pharmacological weakness is that curcumin is absorbed badly — swallow a gram and very little of it reaches your bloodstream. For a knee, that is a serious problem. For a stomach, it may not be a problem at all. The curcumin that never crosses into the blood is still sitting in the gut, in direct contact with the exact tissue you are trying to treat. What is a limitation everywhere else is arguably an advantage here.

These four articles work through what is actually known, what is claimed on thinner ground, and where turmeric is simply the wrong answer — including one trial where a curcumin-based regimen failed outright, which we cover in full because a page that only reports the wins is not worth reading.


Deep-Dive Articles

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. How Turmeric Acts on the Gut
  3. Why the Upper Gut Is the Strongest Indication
  4. What the Evidence Supports — and What It Doesn't
  5. Dosing Quick Reference
  6. How a Whole-Rhizome Capsule Differs From a Concentrated Extract
  7. Cautions
  8. Alarm Symptoms That Point Beyond Indigestion
  9. Key Research Papers
  10. Connections
  11. Featured Videos

How Turmeric Acts on the Gut

Four mechanisms are usually invoked, and they are not equally well supported. Taken together they explain why a single spice keeps appearing in traditional remedies for such different-sounding complaints.

1. Bile flow — the fat-digestion route

Bile is the detergent your liver makes to break dietary fat into droplets small enough for enzymes to work on. It is stored in the gallbladder, a small pouch that squeezes when a fatty meal arrives. Curcumin is a cholagogue — it makes the gallbladder contract — and this is one of the few turmeric mechanisms that has been watched directly in living people. In a placebo-controlled ultrasound study, volunteers who took curcumin showed a clear reduction in gallbladder volume compared with placebo; in plain terms, the gallbladder squeezed and emptied. A later study varied the dose and showed the effect scaled with it, and a magnetic resonance imaging study of gallbladder emptying placed turmeric among the food ingredients that visibly move the gallbladder.

If your discomfort is the particular kind that follows a rich, greasy, celebratory meal, this is the mechanism that most plausibly explains any relief you get. It is also, exactly, why turmeric supplements carry a gallstone warning — the full argument is in Turmeric, Bile and Fat Digestion.

2. Motility — how fast the stomach empties

A large part of functional dyspepsia is a stomach that empties too slowly, or that fails to relax properly to accommodate a meal, so a normal-sized dinner produces an abnormal sense of fullness. Curcumin has been shown to improve gastric emptying in mice, including work implicating the interstitial cells of Cajal — the pacemaker cells that set the rhythm of gut muscle contraction. This is genuinely interesting mechanistic work and it is genuinely animal work. No one has shown the same thing with a gastric emptying study in humans, and it would be wrong to tell you they have. The closest human measurement is a 2009 study of 8 healthy people in which curry with turmeric shortened small-bowel transit time (the passage through the small intestine, not gastric emptying) compared with the same curry without turmeric.

3. Mucosal protection — the stomach lining

Your stomach makes acid strong enough to dissolve metal and protects itself with a mucus and bicarbonate layer plus a rich blood supply. Curcumin appears to support that defence: in rats, it protects the gastric lining against damage from indomethacin (an anti-inflammatory drug notorious for causing ulcers) and against stress-induced injury, and review papers have assembled the mechanisms — antioxidant defence, preserved mucosal blood flow, restrained inflammatory signalling. Again: rats. The human ulcer data are much thinner and much older.

4. Anti-inflammatory action, locally applied

The nuclear factor kappa B (NF-kB) pathway that curcumin is famous for inhibiting is the same pathway that drives inflammation in the bowel wall. In inflammatory bowel disease this stops being theoretical: curcumin has been tested as add-on therapy in ulcerative colitis in properly randomised, placebo-controlled trials, with results that are modest but real. The mechanism reviews describe suppression of NF-kB signalling, reduced pro-inflammatory cytokine production and effects on the epithelial barrier and the microbiome.

Back to Table of Contents

Why the Upper Gut Is the Strongest Indication

Here is the argument in one paragraph, because it is the single most useful idea on this page.

Curcumin is poorly absorbed. Swallow a gram of standard turmeric extract and blood levels barely register; that is why the supplement industry sells piperine-enhanced, phospholipid-complexed and nanoparticle formulations, and why the piperine work from 1998 is one of the most cited turmeric papers in existence. For anything systemic — joints, brain, blood vessels — poor absorption is the central obstacle.

The gut is the one place where that logic inverts. Unabsorbed curcumin is not wasted curcumin if the gut is the target. It stays in the lumen, in contact with the stomach and intestinal lining, at concentrations far higher than anything the bloodstream ever sees, and it reaches the colonic microbiota intact. Lopresti set this argument out formally in a 2018 review, proposing that curcumin's gastrointestinal effects might account for a meaningful share of its overall health effects rather than being an afterthought.

This is not a trick of reasoning to rescue a weak supplement. It is the reason the clinical trial record for gut indications, small and imperfect as it is, looks proportionally better than you would predict from the pharmacokinetics alone — and it is why the poor absorption of a cheap whole-rhizome capsule matters far less for indigestion than it would for arthritis.

Back to Table of Contents

What the Evidence Supports — and What It Doesn't

An honest ledger. Read the lower lists as carefully as the first.

A 2024 systematic review of turmeric for digestive disorders (inflammatory bowel disease, irritable bowel syndrome, dyspepsia, gastroesophageal reflux disease and peptic ulcers) kept 26 studies, found most “to have a high risk of bias”, and reported “possible efficacy in patients with IBD or IBS” but inconsistent effects for the other conditions; it judged the efficacy of turmeric in digestive disorders “unclear”, and no meta-analysis was possible because the studies differed too much.

Reasonably supported

  1. Functional dyspepsia. Two randomised trials, both Thai, separated by thirty-four years, both reporting symptom improvement. The 2023 trial is the better one by a wide margin: three arms, double-blind, curcumin against omeprazole against the combination. This is the best thing turmeric has going in digestion. In the 1989 trial (116 adults), 53% of patients on placebo responded, against 83% on the anti-flatulence remedy and 87% on turmeric. The 2023 trial randomised 206 patients (151 completed) to two 250 mg curcumin capsules four times daily, omeprazole 20 mg once daily, or both, for 28 days; all three groups improved on the Severity of Dyspepsia Assessment (SODA) score, “No significant differences were observed among the three groups”, and no serious adverse events occurred. The authors concluded that curcumin and omeprazole had “comparable efficacy” with “no obvious synergistic effect”. That trial had no placebo arm.
  2. Gallbladder contraction. Directly measured in people by ultrasound, dose-responsive, and corroborated by magnetic resonance imaging work. The mechanism is not in doubt; what is less certain is how much symptom relief it delivers.
  3. Ulcerative colitis, as an add-on. Two randomised, placebo-controlled trials support curcumin alongside standard therapy — one for maintaining remission, one for inducing it on top of mesalamine. Add-on, not replacement. In the maintenance trial, curcumin 1 g after breakfast and 1 g after the evening meal for 6 months, alongside sulfasalazine or mesalamine, was followed by relapse in 2 of 43 patients (4.65%), against 8 of 39 (20.51%) on placebo. In the induction trial, curcumin 3 g/day added to mesalamine brought clinical remission at week 4 in 14 of 26 patients (53.8%), against none of the 24 on placebo. A 2025 meta-analysis of 8 randomised trials (482 patients) found add-on curcumin improved clinical remission compared with placebo (risk ratio, RR=2.33, 95% confidence interval, CI, 1.25 to 4.34), while the rise in endoscopic remission was not statistically significant (RR=4.17, 95% CI 0.63 to 27.71); no serious adverse events were reported, and the trials differed widely in their results (I²=80%).

Weakly supported

  1. Irritable bowel syndrome. The most-quoted study is a pilot with no control group, which in a condition with a famously large placebo response tells you very little. The better irritable bowel syndrome trials used curcumin combined with fennel essential oil, and no trial design can say which of the two ingredients did the work. A 2018 meta-analysis pooled 3 trials (326 patients) and found curcumin had a “beneficial albeit not statistically significant effect” on irritable bowel syndrome symptoms (standardized mean difference -0.466, 95% CI -1.113 to 0.182, p = 0.158).
  2. Peptic ulcer. An uncontrolled Thai phase II study from 2001, plus rat work. Interesting; not proof.
  3. Gas and bloating specifically. A small human study (8 healthy people) measured breath hydrogen — a genuine, objective marker of fermentation in the gut — after curry with and without turmeric. Turmeric increased breath hydrogen, which the authors read as more carbohydrate fermentation in the colon, and shortened small-bowel transit time. It measured gas production, not relief of gas or bloating. Small, and one study.
  4. Gastric emptying and motility. Gastric emptying: mouse work only. Small-bowel transit: the one small human breath-hydrogen study above found turmeric shortened it. Promising, not translated.

Not supported — and one outright failure

  1. Eradicating Helicobacter pylori. A curcumin-based one-week triple therapy was tested and failed. The paper's own subtitle asks whether there is "something to learn from failure". The regimen contained no antibiotic: for 7 days, 25 people with functional dyspepsia took curcumin 30 mg twice daily, bovine lactoferrin, N-acetylcysteine and pantoprazole. It cured the infection in only 3 of the 25 (12%), although dyspeptic symptoms and serum pepsinogens (a blood sign of stomach inflammation) fell at 2 months. Curcumin has been studied as something that may calm the associated inflammation, which is a different claim from eradicating the bacterium.
  2. Replacing a proton pump inhibitor (PPI) in someone who needs one. The 2023 trial tested curcumin in functional dyspepsia — symptoms with no structural disease found on endoscopy. It says nothing about erosive oesophagitis, Barrett's oesophagus, ulcers, or anyone on a proton pump inhibitor for a diagnosed reason.
  3. Any claim of a cure. Functional dyspepsia is a relapsing, remitting condition. Nothing in this literature cures it.

Back to Table of Contents

Dosing Quick Reference

These are the doses the studies on this page actually used. They are descriptive, not a prescription, and they differ meaningfully from the doses used for joints.

  1. Whole-rhizome turmeric capsules, traditional dyspepsia dose — the 1989 Thai trial gave each patient 2 capsules of 250 mg Curcuma domestica four times a day for seven days: with meals and at bedtime. Note the shape of that regimen — a modest amount, frequently, tied to meals, for a short course. It is the pattern a Thai pharmacy label still describes.
  2. Curcumin extract, modern trial dose — the 2023 functional dyspepsia trial used two capsules of 250 mg curcumin four times daily for 28 days, with and without omeprazole 20 mg once daily. Extracts are concentrated: a curcumin extract capsule may carry twenty to thirty times the curcuminoid content of the same weight of dried rhizome.
  3. Food and timing. Every mechanism on this page — bile release, motility, mucosal contact — assumes food is present. Turmeric taken on an empty stomach is described as both less useful and more likely to cause the burning some people report.
  4. Trial length. The dyspepsia trials ran one to four weeks, so the studies say nothing about longer courses in someone who has seen no change by then.
  5. Piperine changes the arithmetic. Black pepper extract dramatically raises curcumin blood levels — which for a gut indication is not obviously the goal, and which also raises the likelihood of drug interactions. A plain preparation without piperine avoids that rise in blood levels.

Back to Table of Contents

How a Whole-Rhizome Capsule Differs From a Concentrated Extract

This distinction matters more for digestion than for any other turmeric indication, and most shoppers never notice it.

A whole-rhizome capsule is dried, powdered turmeric root — the spice, in a capsule. Curcuminoids make up only a small percentage of it; the rest is starch, fibre, minerals, and the volatile oils (turmerone and its relatives) that give turmeric its smell. This is what the Thai dyspepsia tradition uses and what the 1989 trial tested.

A standardised curcumin extract concentrates the curcuminoids, typically to around 95%, and discards nearly everything else. This is what nearly all Western supplements and nearly all modern trials use, and it is what the arthritis literature is built on.

They are not interchangeable, and the assumption that "more curcumin is better" is exactly the assumption the bioavailability argument above calls into question. If the point is contact between curcumin and the gut lining, the concentrated extract wins on quantity. If the point is reproducing a traditional use with a century of pharmacy-shelf experience behind it — and the volatile oils and fibre may not be inert — the whole rhizome has its own case. The honest answer is that no trial has compared them head to head for indigestion.

Back to Table of Contents

Cautions

  1. Gallstones and bile-duct obstruction. The strongest, most mechanistically certain caution on this page. Turmeric makes the gallbladder contract; if a stone is sitting where it can be driven into the duct, that contraction is the hazard. The caution therefore concerns people with known gallstones or a history of bile-duct obstruction who take turmeric supplements; culinary amounts in food are a different matter.
  2. Liver injury. A case series from the US Drug-Induced Liver Injury Network described ten patients with liver injury associated with turmeric supplements. Chemical analysis confirmed turmeric in all 7 products tested, and 3 of them also contained piperine (black pepper); 7 of the 10 patients carried the human leukocyte antigen (HLA) gene variant HLA-B*35:01, which the authors call a “strong linkage”. The injury appeared 1 to 4 months after starting; 5 patients were hospitalised and 1 died of acute liver failure. It is rare against enormous consumption, and it is real. Dark urine, pale stools, yellowing of the eyes or skin, or unexplained exhaustion are signs of liver injury that hospitals treat as urgent.
  3. Oxalate and kidney stones. Turmeric raised urinary oxalate excretion in healthy volunteers in a controlled feeding study: in a 2008 crossover study of 11 healthy people, 91% of turmeric's oxalate was water-soluble against 6% for cinnamon, and the authors concluded that supplemental doses of turmeric “can significantly increase urinary oxalate levels, thereby increasing risk of kidney stone formation in susceptible individuals”.
  4. Blood thinners and antiplatelet drugs. Curcumin has antiplatelet activity, so the concern for people taking warfarin, a direct oral anticoagulant (DOAC), clopidogrel or regular aspirin is an added effect on bleeding.
  5. It can cause the very symptom you are treating. Some people get reflux, burning or loose stools from turmeric capsules; for them the capsules cause the symptom rather than relieve it.
  6. Pregnancy. Culinary use is normal and long-established. Supplement doses are a separate question from culinary use.

The full interactions picture is in the companion Turmeric Safety and Interactions leg.

Back to Table of Contents

Alarm Symptoms That Point Beyond Indigestion

Indigestion is usually benign and usually functional. Sometimes it is the first sign of something that will not wait. Doctors treat the following as alarm features in someone with indigestion — signs that it may be something else, whatever remedy is being used:

These are the standard alarm features. Their whole purpose is to catch the small number of people whose "indigestion" is something else, early enough to matter.

Back to Table of Contents

Key Research Papers

  1. Kongkam P, Khongkha W, Lopimpisuth C, et al. (2023). Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial. BMJ Evidence-Based Medicine. — PubMed PMID: 37696679
  2. Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, et al. (1989). Randomized double blind study of Curcuma domestica Val. for dyspepsia. Journal of the Medical Association of Thailand. — PubMed PMID: 2699615
  3. Lopresti AL (2018). The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Advances in Nutrition. — PubMed PMID: 29438458
  4. Rasyid A, Lelo A (1999). The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Alimentary Pharmacology & Therapeutics. — PubMed PMID: 10102956
  5. Marciani L, Cox EF, Hoad CL, et al. (2013). Effects of various food ingredients on gall bladder emptying. European Journal of Clinical Nutrition. — PubMed PMID: 24045793
  6. Hanai H, Iida T, Takeuchi K, et al. (2006). Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology. — PubMed PMID: 17101300
  7. Lang A, Salomon N, Wu JC, et al. (2015). Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. — PubMed PMID: 25724700
  8. Di Mario F, Cavallaro LG, Nouvenne A, et al. (2007). A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter. — PubMed PMID: 17493004
  9. Bundy R, Walker AF, Middleton RW, et al. (2004). Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. Journal of Alternative and Complementary Medicine. — PubMed PMID: 15673996
  10. Kwiecien S, Magierowski M, Majka J, et al. (2019). Curcumin: A Potent Protectant against Esophageal and Gastric Disorders. International Journal of Molecular Sciences. — PubMed PMID: 30909623
  11. Burge K, Gunasekaran A, Eckert J, et al. (2019). Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. International Journal of Molecular Sciences. — PubMed PMID: 31003422
  12. Shimouchi A, Nose K, Takaoka M, et al. (2009). Effect of dietary turmeric on breath hydrogen. Digestive Diseases and Sciences. — PubMed PMID: 19034660
  13. Halegoua-DeMarzio D, Navarro V, Ahmad J, et al. (2023). Liver Injury Associated with Turmeric — A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]. American Journal of Medicine. — PubMed PMID: 36252717
  14. Tang M, Larson-Meyer DE, Liebman M (2008). Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. American Journal of Clinical Nutrition. — PubMed PMID: 18469248
  15. Thavorn K, Wolfe D, Faust L, et al. (2024). A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders. Phytotherapy Research. — PubMed PMID: 38503513
  16. Peng Z, Li D, Wu N, et al. (2025). Safety and efficacy of curcumin in the treatment of ulcerative colitis: An updated systematic review and meta-analysis of randomized controlled trials. Explore (NY). — PubMed PMID: 39612780
  17. Ng QX, Soh AYS, Loke W, et al. (2018). A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS). Journal of Clinical Medicine. — PubMed PMID: 30248988
  18. Chamchoum E, Ghaleb J, Chamchoum N, et al. (2026). Functional Dyspepsia: An Updated Review of Pathophysiology, Epidemiology, Clinical Manifestations, and International Management Guidelines. Sage Open Pathology. — PubMed PMID: 42491169

PubMed Topic Searches

  1. PubMed: Curcumin and functional dyspepsia
  2. PubMed: Turmeric and digestion, clinical trials
  3. PubMed: Curcumin, gallbladder and bile
  4. PubMed: Curcumin and irritable bowel syndrome
  5. PubMed: Curcumin and ulcerative colitis, randomised trials
  6. PubMed: Curcuma longa and Helicobacter pylori
  7. PubMed: Curcumin and gastric mucosal protection

Back to Table of Contents

Connections

Back to Table of Contents